Epilepsy is a leading neurological condition characterized by recurrent seizures and affecting more than 50 million people worldwide [1]. There is a disproportionate geographical burden of epilepsy, with 80% of cases living in low- and middle-income countries [1]. In sub–Saharan Africa (SSA), the estimated median prevalence of epilepsy is 14.2 per 1000 [2]; there is a peak prevalence in the 20–29 years age group, with both sexes being equally affected particularly for individuals under 40 years [3].
8
SEP
SEP
0